Principal Scientist Merck & Co, Inc. Boston, Massachusetts
Join Pierre Daublain and several authors in Poster Forum #8 in the Solution Center for a conversation about posters Sponsored by Merck.
M1030-07-37 GRP78 Targeting of Long-Acting Hydra-Elastin-Like Polypeptides (ELPs) Carrying Rapamycin to Breast Cancer, Sara Aly Attia, BS, University of Southern California
M1530-01-03 Targeted Cell-Penetrating Peptide-Drug Conjugates for the Treatment of Pancreatic Cancer, Oluwabukunmi Olajubutu, MS, Howard University
M1430-05-27 Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation, Drishti Rathod, MS, St. John’s University
M0930-05-29 Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics, Nihan Yonet-Tanyeri, Ph.D., University of Pittsburgh
M1330-01-02 Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery, Hy Dinh Nguyen, MS, Ajou University